Microcirculatory Dysfunction as a Central Driver of Disease Severity in Acute Pancreatitis: Mechanisms and Therapeutic Targets
Main Article Content
Abstract
Acute pancreatitis (AP) remains a complex inflammatory disease in which early microcirculatory failure plays a central role in determining severity, organ dysfunction, and clinical outcomes. Despite major advances in understanding its pathobiology, therapeutic strategies targeting microvascular impairment, endothelial injury, and perfusion disturbances remain fragmented and inconsistently translated into practice. This comprehensive narrative review critically synthesizes current evidence on pancreatic microcirculatory dysfunction and its therapeutic implications. We integrate data from contemporary models, including endothelial glycocalyx degradation, capillary leak phenomena, leukocyte–endothelium interactions, mitochondrial dysfunction, and splanchnic hypoperfusion, establishing microcirculatory collapse as a unifying mechanism in the progression to severe AP.
Furthermore, the review critically evaluates therapeutic interventions aimed at maintaining or restoring microvascular integrity, including optimized fluid resuscitation, low-molecular-weight heparin, ulinastatin, epidural analgesia, continuous hemofiltration, and experimental endothelial-protective agents. Evidence suggests that early, controlled hydration, anticoagulation in select cases, and epidural strategies may improve perfusion and reduce complications, while emerging therapies targeting glycocalyx preservation, mitochondrial stability, and SIRT1-FOXO1 pathways show promising translational potential. However, heterogeneity among studies, limited high-quality randomized trials, and variations in timing and patient selection highlight persistent gaps.
Overall, this review consolidates microcirculatory dysfunction as a central therapeutic target in acute pancreatitis and underscores the need for standardized protocols, high-quality RCTs, and precision-based approaches to modify the early trajectory of severe disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ, Shaheen AA, Swain M, Buie M, Underwood FE, Kaplan GG. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and
II. Meta-Analysis. Gastroenterology. 2022 Jan;162(1):122-134.
doi: 10.1053/j.gastro.2021.09.043.
III. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun;144(6):1252-61.
doi: 10.1053/j.gastro.2013.01.068.
IV. Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):479-496.
doi: 10.1038/s41575-019-0158-2.
V. Gao W, Yang HX, Ma CE. The Value of BISAP Score for Predicting Mortality and Severity in Acute Pancreatitis: A Systematic Review and Meta-Analysis. PLoS One. 2015 Jun 19;10(6):e0130412. doi: 10.1371/journal.pone.0130412. Erratum in: PLoS One. 2015 Oct 29;10(10):e0142025.
doi: 10.1371/journal.pone.0142025.
VI. Garg PK, Singh VP. Organ Failure Due to Systemic Injury in Acute Pancreatitis. Gastroenterology. 2019 May;156(7):2008-2023.
doi: 10.1053/j.gastro.2018.12.041.
VII. Glaubitz J, Asgarbeik S, Lange R, Mazloum H, Elsheikh H, Weiss FU, Sendler M. Immune response mechanisms in acute and chronic pancreatitis: strategies for therapeutic intervention. Front Immunol. 2023 Oct 10;14:1279539.
doi: 10.3389/fimmu.2023.1279539.
VIII. Rosales-Muñoz GJ, Souza-Arroyo V, Bucio-Ortiz L, Miranda-Labra RU, Gomez-Quiroz LE, Gutiérrez-Ruiz MC. Acute pancreatitis experimental models, advantages and disadvantages. J Physiol Biochem. 2025 Aug;81(3):539-556.
doi: 10.1007/s13105-025-01091-w. Epub 2025 May 17. Erratum in: J Physiol Biochem. 2025 Aug;81(3):831-832. doi: 10.1007/s13105-025-01102-w.
IX. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779.
X. Zhou ZG, Chen YD. Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. World J Gastroenterol. 2002 Jun;8(3):406-12. doi: 10.3748/wjg.v8.i3.406.
XI. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8(3):187-94. doi: 10.1007/s005340170015.
XII. Foitzik T, Eibl G, Hotz B, Hotz H, Kahrau S, Kasten C, Schneider P, Buhr HJ. Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. Dig Dis Sci. 2002 Jan;47(1):130-8. doi: 10.1023/a:1013284008219.
XIII. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol. 2000 Feb;190(2):117-25. doi: 10.1002/(SICI)1096-9896(200002)190:2<117::AID-PATH494>3.0.CO;2-K.
XIV. Głuszek S, Nawacki Ł, Matykiewicz J, Kot M, Kuchinka J. Severe Vascular Complications Of Acute Pancreatitis. Pol Przegl Chir. 2015 Oct;87(10):485-90. doi: 10.1515/pjs-2015-0093.
XV. Sakorafas GH, Tsiotos GG, Sarr MG. Ischemia/Reperfusion-Induced pancreatitis. Dig Surg. 2000;17(1):3-14. doi: 10.1159/000018793.
XVI. Wang J, Zou Y, Chang D, Hong DQ, Zhang J. Protective effect of Dachengqi decoction on the pancreatic microcirculatory system in severe acute pancreatitis by down-regulating HMGB-TLR-4-IL-23-IL-17A mediated neutrophil activation by targeting SIRT1. Gland Surg. 2021 Oct;10(10):3030-3044. doi: 10.21037/gs-21-655.
XVII. Li Y, Li J, Li S, Zhou S, Yang J, Xu K, Chen Y. Exploring the gut microbiota's crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles. Front Pharmacol. 2024 Jul 26;15:1437894.
doi: 10.3389/fphar.2024.1437894.
XVIII. Li H, Wen H, Liu J, Luo X, Pei B, Ge P, Sun Z, Liu J, Wang J, Chen H. The glycocalyx: a key target for treatment of severe acute pancreatitis-associated multiple organ dysfunction syndrome. Hum Cell. 2025 May 24;38(4):107.
doi: 10.1007/s13577-025-01227-6.
XIX. Khamaysi I, Singh P, Nasser S, Awad H, Chowers Y, Sabo E, Hammond E, Gralnek I, Minkov I, Noseda A, Ilan N, Vlodavsky I, Abassi Z. The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target. Sci Rep. 2017 Apr 6;7(1):715. doi: 10.1038/s41598-017-00715-6.
XX. Zhu L, Xu Y, Lei J. Molecular mechanism and potential role of mitophagy in acute pancreatitis. Mol Med. 2024 Sep 3;30(1):136.
doi: 10.1186/s10020-024-00903-x.
XXI. Rong Y, Ren J, Song W, Xiang R, Ge Y, Lu W, Fu T. Resveratrol Suppresses Severe Acute Pancreatitis-Induced Microcirculation Disturbance through Targeting SIRT1-FOXO1 Axis. Oxid Med Cell Longev. 2021 Feb 9;2021:8891544.
doi: 10.1155/2021/8891544.
XXII. Wu Y, Han C, Luo R, Cai W, Xia Q, Jiang R, Ferdek PE, Liu T, Huang W. Molecular mechanisms of pain in acute pancreatitis: recent basic research advances and therapeutic implications. Front Mol Neurosci. 2023 Dec 22;16:1331438.
doi: 10.3389/fnmol.2023.1331438.
XXIII. Tsuji Y, Takahashi N, Isoda H, Koizumi K, Koyasu S, Sekimoto M, Imanaka Y, Yazumi S, Asada M, Nishikawa Y, Yamamoto H, Kikuchi O, Yoshida T, Inokuma T, Katsushima S, Esaka N, Okano A, Kawanami C, Kakiuchi N, Shiokawa M, Kodama Y, Moriyama I, Kajitani T, Kinoshita Y, Chiba T. Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis. J Gastroenterol. 2017 Oct;52(10):1130-1139.
doi: 10.1007/s00535-017-1330-5. Epub 2017 Apr 3. Erratum in: J Gastroenterol. 2017 Oct;52(10):1147-1148. doi: 10.1007/s00535-017-1343-0.
XXIV. Reuken PA, Brozat JF, Quickert S, Ibidapo-Obe O, Reißing J, Franz A, Stengel S, Teichgräber UK, Kiehntopf M, Trautwein C, Stallmach A, Koch A, Bruns T. Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis. J Intensive Care. 2022 Jun 11;10(1):28. doi: 10.1186/s40560-022-00619-2.
XXV. Madrigal TPR, Panlilio MTT, Burog AILD, Danguilan RA, Chavez JR. Incidence of acute pancreatitis among patients with leptospirosis requiring extracorporeal membrane oxygenation (ECMO): a descriptive study. BMJ Open Gastroenterol.2023 Mar;10(1):e001094.
doi: 10.1136/bmjgast-2022-001094.
XXVI. Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute pancreatitis. Lancet. 2020 Sep 5;396(10252):726-734. doi: 10.1016/S0140-6736(20)31310-6. Erratum in: Lancet. 2021 Nov 6;398(10312):1686. doi: 10.1016/S0140-6736(21)02377-1.
XXVII. Foitzik T, Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery. 2000 Sep;128(3):399-407. doi: 10.1067/msy.2000.107104.
XXVIII. Ca S, Gondesi K, K KP, Yarremsetty SV. Efficacy of Low-Molecular-Weight Heparin in the Treatment of Severe Acute Pancreatitis: A Comparative Study at a Tertiary Health Center. Cureus. 2024 Jul 30;16(7):e65736. doi: 10.7759/cureus.65736.
XXIX. He W, Ding L, Liu Z, Hua M, Zhou Y, Gong M, Sheng J, Wu X, Fan H, Shu H, Wang R, Xun L, Huang C, Guo F, Cao C, Zhan Z, Chen H, Qian X, Liu Q, Li Q, Tang Z, Xiong Y, Xie P, Yu B, Wan J, Ke H, Wu Y, Hu Y, Ai J, Huang X, Lei Y, Xiong H, Liu Z, Zhu Y, Luo L, Xia L, Ke L, Cai W, Huang W, Li W, Windsor J, Sutton R, Lv N, Zhu Y; Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG). Low-Molecular-Weight Heparin Plus Insulin in Hypertriglyceridemic Acute Pancreatitis: A Randomized Clinical Trial. JAMA Netw Open. 2025 Nov 3;8(11):e2542124.
doi: 10.1001/jamanetworkopen.2025.42124.
XXX. Bachmann KA, Trepte CJ, Tomkötter L, Hinsch A, Stork J, Bergmann W, Heidelmann L, Strate T, Goetz AE, Reuter DA, Izbicki JR, Mann O. Effects of thoracic epidural anesthesia on survival and microcirculation in severe acute pancreatitis: a randomized experimental trial. Crit Care. 2013 Dec 5;17(6):R281. doi: 10.1186/cc13142.
XXXI. Sadowski SM, Andres A, Morel P, Schiffer E, Frossard JL, Platon A, Poletti PA, Bühler L. Epidural anesthesia improves pancreatic perfusion and decreases the severity of acute pancreatitis. World J Gastroenterol. 2015 Nov 21;21(43):12448-56. doi: 10.3748/wjg.v21.i43.12448.
XXXII. Windisch O, Heidegger CP, Giraud R, Morel P, Bühler L. Thoracic epidural analgesia: a new approach for the treatment of acute pancreatitis? Crit Care. 2016 May 4;20(1):116.
doi: 10.1186/s13054-016-1292-7.
XXXIII. Li XW, Wang CH, Dai JW, Tsao SH, Wang PH, Tai CC, Chien RN, Shao SC, Lai EC. Comparison of clinical outcomes between aggressive and non-aggressive intravenous hydration for acute pancreatitis: a systematic review and meta-analysis. Crit Care. 2023 Mar 22;27(1):122.
doi: 10.1186/s13054-023-04401-0.
XXXIV. Guo J, Hong J, He Y, Li Q, Huang T, Lou D, Zhang J. Comparison of early aggressive versus nonaggressive fluid resuscitation in acute pancreatitis: a meta-analysis. Therap Adv Gastroenterol. 2023 Aug 22;16:17562848231192144.
doi: 10.1177/17562848231192144.
XXXV. Lee A, Ko C, Buitrago C, Hiramoto B, Hilson L, Buxbaum J; NS-LR Study Group. Lactated Ringers vs Normal Saline Resuscitation for Mild Acute Pancreatitis: A Randomized Trial. Gastroenterology. 2021 Feb;160(3):955-957.e4. doi: 10.1053/j.gastro.2020.10.044.
XXXVI. de-Madaria E, Herrera-Marante I, González-Camacho V, Bonjoch L, Quesada-Vázquez N, Almenta-Saavedra I, Miralles-Maciá C, Acevedo-Piedra NG, Roger-Ibáñez M, Sánchez-Marin C, Osuna-Ligero R, Gracia Á, Llorens P, Zapater P, Singh VK, Moreu-Martín R, Closa D. Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial. United European Gastroenterol J. 2018 Feb;6(1):63-72.
doi: 10.1177/2050640617707864.
XXXVII. Theakarajan R, Ashuvanth S, Rajagopalan G. From pain relief to organ protection: epidural analgesia in acute pancreatitis-a narrative review of its evolving role. Clin J Gastroenterol. 2025 Aug 22. doi: 10.1007/s12328-025-02204-0.
XXXVIII. Wang SQ, Jiao W, Zhang J, Zhang JF, Tao YN, Jiang Q, Yu F. Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial. World J Clin Cases. 2023 Jul 6;11(19):4601-4611. doi: 10.12998/wjcc.v11.i19.4601.
XXXIX. He K, Gao L, Yang Z, Zhang Y, Hua T, Hu W, Wu D, Ke L. Aggressive versus controlled fluid resuscitation in acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials. Chin Med J (Engl). 2023 May 20;136(10):1166-1173.
doi: 10.1097/CM9.0000000000002684.
XL. Yin Y, Wang L, Gao F, Liu L, Qi X. Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231188718.
doi: 10.1177/10760296231188718.
XLI. Yadav SC, Zhang B. Effect of Early Continuous Veno-Venous Haemofiltration in Severe Acute Pancreatitis for the Prevention of Local Pancreatic Complications. Gastroenterol Res Pract. 2022 Mar 7;2022:7575231. doi: 10.1155/2022/7575231.
XLII. Hu Y, Xiong W, Li C, Cui Y. Continuous blood purification for severe acute pancreatitis: A systematic review and meta-analysis. Medicine (Baltimore). 2019 Mar;98(12):e14873.
doi: 10.1097/MD.0000000000014873.
XLIII. Lee PJ, Papachristou GI. Management of Severe Acute Pancreatitis. Curr Treat Options Gastroenterol. 2020;18(4):670-681.
doi: 10.1007/s11938-020-00322-x.
XLIV. van den Berg FF, Boermeester MA. Update on the management of acute pancreatitis. Curr Opin Crit Care. 2023 Apr 1;29(2):145-151.
doi: 10.1097/MCC.0000000000001017.
XLV. Antkowiak R, Bialecki J, Chabowski M, Domoslawski P. Treatment of Microcirculatory Disturbances in Acute Pancreatitis: Where Are We Now? Pancreas. 2022 May 1;51(5):415-421.
doi: 10.1097/MPA.0000000000002044.
XLVI. Zaman S, Gorelick F. Acute pancreatitis: pathogenesis and emerging therapies. J Pancreatol. 2024 Mar;7(1):10-20.
doi: 10.1097/JP9.0000000000000168.
XLVII. Sarri G, Guo Y, Iheanacho I, Puelles J. Moderately severe and severe acute pancreatitis : a systematic review of the outcomes in the USA and European Union-5. BMJ Open Gastroenterol. 2019 Feb 16;6(1):e000248. doi: 10.1136/bmjgast-2018-000248.